Clinical Trial Update: Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing intralesional MMR vaccine, intralesional candidal antigen, and topical podophyllin for genital warts (Condylomata Acuminata).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Condylomata Acuminata
• Genital Warts

Drugs mentioned

• intralesional MMR vaccine
• intralesional candidal antigen
• topical podophyllin (podophyllin)

Snippet

Sponsor: Assiut University | Conditions: Condylomata Acuminata | Phase 3 | Status: UNKNOWN